1. Home
  2. ACOG vs WEA Comparison

ACOG vs WEA Comparison

Compare ACOG & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.88

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Logo Western Asset Bond Fund Share of Beneficial Interest

WEA

Western Asset Bond Fund Share of Beneficial Interest

HOLD

Current Price

$10.64

Market Cap

125.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACOG
WEA
Founded
2000
2002
Country
Canada
United States
Employees
57
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
110.4M
125.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACOG
WEA
Price
$5.88
$10.64
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
29.6K
33.7K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
7.87%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$139.22
N/A
Revenue Next Year
$134.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.50
$10.30
52 Week High
$10.88
$11.44

Technical Indicators

Market Signals
Indicator
ACOG
WEA
Relative Strength Index (RSI) 49.17 51.90
Support Level $5.73 $10.48
Resistance Level $6.34 $10.72
Average True Range (ATR) 0.38 0.09
MACD 0.01 0.01
Stochastic Oscillator 68.48 81.82

Price Performance

Historical Comparison
ACOG
WEA

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The fund invests in bonds of companies operating in different sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

Share on Social Networks: